Add Company
Join Now

Amber Therapeutics Revenue and Competitors

License our Company Data API

London, England

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Amber Therapeutics's estimated annual revenue is currently $2.1M per year.(i)
  • Amber Therapeutics's estimated revenue per employee is $77,500

Employee Data

  • Amber Therapeutics has 27 Employees.(i)
  • Amber Therapeutics grew their employee count by 170% last year.

Amber Therapeutics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.4M1813%N/AN/A
#2
$1.7M2210%N/AN/A
#3
$0.5M7-22%N/AN/A
#4
$2.9M3823%N/AN/A
#5
$2M2624%N/AN/A
#6
$1.7M220%N/AN/A
#7
$5.5M7125%N/AN/A
#8
$2M2673%N/AN/A
#9
$1.6M2054%N/AN/A
#10
$1.2M1633%N/AN/A
Add Company

What Is Amber Therapeutics?

Amber Therapeutics is a University of Oxford spinout developing next-generation, intelligent bioelectrical therapies to transform clinical outcomes in patients with functional disorders of the peripheral nervous system. Amber’s approach leverages closed-loop intelligence to create ‘synthetic reflex arcs’ that can sense, interpret, adapt and respond to a patient’s individual signals thereby restoring normal physiological function. Amber Therapeutics was founded by a multidisciplinary team of clinicians, translational neuroengineers, medtech industry professionals and experienced entrepreneurs focused on developing transformational therapy innovation for major unmet medical conditions. The Company was spun out from the University of Oxford in 2021 and is backed by Oxford Science Enterprises and 8VC.

keywords:N/A

N/A

Total Funding

27

Number of Employees

$2.1M

Revenue (est)

170%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.7M2713%N/A
#2
$2.7M27-4%N/A
#3
$4.9M27-23%$24.6M
#4
$2.7M270%N/A
#5
$3.9M27-10%N/A